1/12
08:01 am
espr
Form 8-K Esperion Therapeutics, For: Jan 11
High
Report
Form 8-K Esperion Therapeutics, For: Jan 11
12/18
04:10 pm
espr
Form 4 Esperion Therapeutics, For: Dec 17 Filed by: Koenig Sheldon L.
Medium
Report
Form 4 Esperion Therapeutics, For: Dec 17 Filed by: Koenig Sheldon L.
12/18
04:09 pm
espr
Form 4 Esperion Therapeutics, For: Dec 17 Filed by: Looker Benjamin
Medium
Report
Form 4 Esperion Therapeutics, For: Dec 17 Filed by: Looker Benjamin
12/18
04:09 pm
espr
Form 4 Esperion Therapeutics, For: Dec 17 Filed by: Halladay Benjamin
Medium
Report
Form 4 Esperion Therapeutics, For: Dec 17 Filed by: Halladay Benjamin
12/17
03:52 pm
espr
Form 144 Esperion Therapeutics, Filed by: Koenig Sheldon L.
Low
Report
Form 144 Esperion Therapeutics, Filed by: Koenig Sheldon L.
12/17
03:26 pm
espr
Form 144 Esperion Therapeutics, Filed by: Looker Benjamin
Neutral
Report
Form 144 Esperion Therapeutics, Filed by: Looker Benjamin
12/17
03:18 pm
espr
Form 144 Esperion Therapeutics, Filed by: Halladay Benjamin
Low
Report
Form 144 Esperion Therapeutics, Filed by: Halladay Benjamin
12/8
04:27 pm
espr
Form 4 Esperion Therapeutics, For: Dec 04 Filed by: Harlow John B. Jr.
Medium
Report
Form 4 Esperion Therapeutics, For: Dec 04 Filed by: Harlow John B. Jr.
11/17
04:09 pm
espr
Form 3 Esperion Therapeutics, For: Nov 17 Filed by: Harlow John B. Jr.
Low
Report
Form 3 Esperion Therapeutics, For: Nov 17 Filed by: Harlow John B. Jr.
11/14
11:44 am
espr
Form SCHEDULE 13G/A Esperion Therapeutics, Filed by: Two Seas Capital LP
Low
Report
Form SCHEDULE 13G/A Esperion Therapeutics, Filed by: Two Seas Capital LP
11/12
03:32 pm
espr
Form SCHEDULE 13G/A Esperion Therapeutics, Filed by: WASATCH ADVISORS LP
Medium
Report
Form SCHEDULE 13G/A Esperion Therapeutics, Filed by: WASATCH ADVISORS LP
11/6
04:13 pm
espr
Form 10-Q Esperion Therapeutics, For: Sep 30
Medium
Report
Form 10-Q Esperion Therapeutics, For: Sep 30
11/6
07:32 am
espr
Form 8-K Esperion Therapeutics, For: Nov 06
Medium
Report
Form 8-K Esperion Therapeutics, For: Nov 06
11/4
08:50 am
espr
Form 8-K Esperion Therapeutics, For: Nov 04
Low
Report
Form 8-K Esperion Therapeutics, For: Nov 04